Clinical Trial Update: Corifollitropin Alfa Followed by Menotropin for Poor Ovarian Responders Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating corifollitropin alfa followed by menotropin for poor ovarian responders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diminished Ovarian Reserve
• Infertility

Drugs mentioned

• Elonva (corifollitropin alfa)
• Menotropin (menotropin)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Infertility, Poor Ovarian Response | Phase 3 | Status: COMPLETED